Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Brain, Head and Neck, and Spine Cancer
- Adults aged 18 and over.
- Men and women without regard to ethnic background.
- Patients/Subjects able to give informed consent
- Patients/Subjects whose weight does not exceed 275 lbs.
- Patient with a known or suspected head and neck cancer spine metastases or primary or
secondary brain tumors scheduled for an MRI scan as part of their routine care --OR--
- Volunteer with no history of the disease in that category.
- Patients who are unwilling or unable to undergo MRI including patients with
contra-indications to MRI such as the presence of cardiac pacemakers or
non-compatible intracranial vascular clips.
Type of Study:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
feasibility of high resolution diffusion-weighted imaging
using a new DWI pulse sequence from the manufacturer (General Electric Medical Systems (Milwaukee, WI)) for the assessment of head and neck cancer cancer, spine metastases or primary or secondary brain tumors.
Outcome Time Frame:
Amita Dave, PhD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
- Head and Neck Cancer
- Spine Metastases
- Primary Brain Tumors
- Secondary Brain Tumors
- MR imaging Pulse Sequence
- High Resolution Diffusion-weighted
- Body Weight
- Brain Neoplasms
- Head and Neck Neoplasms
- Neoplasm Metastasis
- Spinal Cord Neoplasms
|Memorial Sloan-Kettering Cancer Center 1275 York Avenue||New York, New York 10021|